Share this article
World Hemophilia Day 2021
MONTRÉAL, April 17, 2021 /PRNewswire/ - April 17, 2021 is World Hemophilia Day. The theme of the event this year is Adapting to change: sustaining care in a new world . This important event is about bringing the global bleeding disorders community together. With the COVID-19 pandemic having a major impact on people with a bleeding disorder, that objective has never been more important. Our community is made up of a great diversity of people from patients and their families, to carers, physicians and researchers each of whom has been affected by the pandemic in a different way. We need to continue providing support to these people now, and in the future once the pandemic has passed. The world has changed greatly over the last year, but one thing hasn t: we are still in this together, and we will always be stronger together as a community in our shared vision of Treatment for All .
Adapting to change: sustaining care in a new world
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Enzyme Replacement Therapy Market Research By Growth Analysis, Competitive Methods And Forecast To 2
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
To embed, copy and paste the code into your website or blog:
One year ago, World Health Organization Director-General Tedros Adhanom declared the COVID-19 outbreak to be a pandemic. At the time of the announcement, the WHO noted that there were 118,000 cases reported globally, but in its most recent situation report, the WHO indicated that as of March 7, 2021 there have been 116,166,652 cases globally.
The response to the COVID-19 pandemic by the global biopharmaceutical industry over the past fourteen months has been unprecedented. From December 30, 2019, when SARS coronavirus was first detected in a patient sample, and January 10, 2020, when the complete genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was released, multiple treatments and vaccines have been developed and approved for use in combating COVID-19. And the rapid development of these treatments and vaccines has, as the Pharmaceutical Research and Manufacturers of America (PhRMA) recently put i